We are live on ! Find out more
BJ

Brouwer & Janachowski Portfolio holdings

AUM $574M
1-Year Est. Return 24.29%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+24.29%
3 Year Est. Return
+41.76%
5 Year Est. Return
+69.42%
10 Year Est. Return
AUM
$489M
AUM Growth
+$30.7M
Cap. Flow
+$23M
Cap. Flow %
4.71%
Top 10 Hldgs %
79.5%
Holding
54
New
2
Increased
21
Reduced
20
Closed
3
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
51
Microsoft
MSFT
$2.98T
$203K 0.04%
+2,939
New +$202K
IBB icon
52
iShares Biotechnology ETF
IBB
$9.23B
-3,846
Closed -$376K
IBM icon
53
IBM
IBM
$206B
-1,889
Closed -$314K
MRK icon
54
Merck
MRK
$315B
-4,129
Closed -$250K

Similar funds

Brouwer & Janachowski's Q2 2017 Portfolio in Review

As of Q2 2017, Brouwer & Janachowski held 54 positions worth $489M, up 6.7% from $458M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Brouwer & Janachowski deployed $23M of net new capital in Q2 2017, opening 2 new positions and adding to 21 existing holdings. Its largest new stake was Honeywell: 3,086 shares worth $372K.

By sector, the portfolio is most concentrated in Financials at 7.7% of assets, down from 7.9% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Schwab US Broad Market ETF, an estimated $2.25M trimmed.

  • Brouwer & Janachowski's largest Q2 2017 buy was Honeywell: 3,086 shares worth $372K.
  • Brouwer & Janachowski added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $9.28M increase.
  • Brouwer & Janachowski's biggest Q2 2017 reduction was Schwab US Broad Market ETF, cutting an estimated $2.25M.
  • Brouwer & Janachowski fully exited iShares Biotechnology ETF in Q2 2017, selling an estimated $376K.
  • Brouwer & Janachowski's ten largest holdings make up 80% of its $489M portfolio in Q2 2017.
  • Brouwer & Janachowski opened 2 new positions and closed 3 in Q2 2017.
  • Brouwer & Janachowski's portfolio value rose 6.7% quarter-over-quarter to $489M.

Based on Brouwer & Janachowski's 13F filing for Q2 2017, filed 21 Jul 2017.